| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
1 British Columbia Cancer Research Centre, and Departments of 2 Pathology and Laboratory Medicine and 3 Oral Biological and Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
Requests for reprints: Corisande Baldwin, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3. Phone: 604-675-8112; Fax: 604-675-8185; E-mail: cbaldwin{at}bccrc.ca.
The development of array comparative genomic hybridization (array CGH) at tiling-path resolution has enabled the detection of gene-sized segmental DNA copy number gains and losses. Here, we present the first application of whole genome tiling-path array CGH to archival clinical specimens for the detailed analysis of oral squamous cell carcinomas (OSCC). We describe the genomes of 20 OSCCs as well as a selection of matched normal DNA in unprecedented detail. Examination of their whole genome profiles enabled the identification of alterations ranging in size from whole-arm, segmental, to gene size alterations. Tiling-path resolution enabled the detection of many more alterations within each tumor than previously reported, many of which include narrow alterations found to be frequent events among the 20 OSCCs. We report the presence of several novel frequent submegabase alterations, such as the 0.58 Mb gain at 5p15.2 containing triple functional domain (TRIO), detected in 45% of cases. We also report the first coamplification of two gene clusters, by fine-mapping the precise base pair boundaries of the high-level amplification at 11q22.2-22.3 containing both matrix metalloproteinase and baculoviral IAP repeat-containing protein 2 (BIRC) gene clusters. These results show the large improvement in detection sensitivity and resolution compared with genome interval marker arrays and the utility of tiling resolution array CGH for the detection of both submegabase and single copy gains and losses in cancer gene discovery.
This article has been cited by other articles:
|
|
 |
|
  J. Zhang, G. A. Smolen, and D. A. Haber Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway Cancer Res., April 15, 2008; 68(8): 2789 - 2794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Kozaki, I. Imoto, S. Mogi, K. Omura, and J. Inazawa Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer Cancer Res., April 1, 2008; 68(7): 2094 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhao, X. Wei, W. Li, R. S. Udan, Q. Yang, J. Kim, J. Xie, T. Ikenoue, J. Yu, L. Li, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes & Dev., November 1, 2007; 21(21): 2747 - 2761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Shah, W. L. Lam, R. T. Ng, and K. P. Murphy Modeling recurrent DNA copy number alterations in array CGH data Bioinformatics, July 1, 2007; 23(13): i450 - i458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Overholtzer, J. Zhang, G. A. Smolen, B. Muir, W. Li, D. C. Sgroi, C.-X. Deng, J. S. Brugge, and D. A. Haber Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon PNAS, August 15, 2006; 103(33): 12405 - 12410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Albertson, A. M. Snijders, J. Fridlyand, R. Jordan, D. Pinkel, B. L. Schmidt, C. Baldwin, C. Garnis, L. Zhang, M. Rosin, et al. Genomic analysis of tumors by array comparative genomic hybridization: more is better. Cancer Res., April 1, 2006; 66(7): 3955 - 3956. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
